Published in Cancer Weekly, February 25th, 2003
This discovery has promising therapeutic implications for the treatment of neurofibromatosis type 1 (NF1), a common hereditary disease that results from mutations in the neurofibromin gene, as well as the approximately 30% of human tumors that have altered Ras activity.
The report is published in the February 15, 2003, issue of Genes & Development.
Neurofibromin is a tumor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.